Cancer Anorexia-Cachexia Syndrome Drug Market, Global Outlook and Forecast 2022-2028
Report Code: KNJ1281244 No. of Pages: 78 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Cancer Anorexia-Cachexia Syndrome Drug in global, including the following market information:
Global Cancer Anorexia-Cachexia Syndrome Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Cancer Anorexia-Cachexia Syndrome Drug companies in 2021 (%)
The global Cancer Anorexia-Cachexia Syndrome Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NEO-1940 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Anorexia-Cachexia Syndrome Drug include Acacia Pharma Ltd, Aeterna Zentaris Inc, Aphios Corp, Incyte Corp, Lakewood-Amedex Inc, Novartis AG, Obexia AG, PsiOxus Therapeutics Ltd and RaQualia Pharma Inc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Anorexia-Cachexia Syndrome Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Anorexia-Cachexia Syndrome Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, by Type, 2021 (%)
NEO-1940
C-1889
DLN-101
Foxo1-nRNA
AVGN-7
Others
Global Cancer Anorexia-Cachexia Syndrome Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Cancer Anorexia-Cachexia Syndrome Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Cancer Anorexia-Cachexia Syndrome Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Anorexia-Cachexia Syndrome Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Anorexia-Cachexia Syndrome Drug revenues share in global market, 2021 (%)
Key companies Cancer Anorexia-Cachexia Syndrome Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Cancer Anorexia-Cachexia Syndrome Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acacia Pharma Ltd
Aeterna Zentaris Inc
Aphios Corp
Incyte Corp
Lakewood-Amedex Inc
Novartis AG
Obexia AG
PsiOxus Therapeutics Ltd
RaQualia Pharma Inc
Viking Therapeutics Inc
1 Introduction to Research & Analysis Reports
1.1 Cancer Anorexia-Cachexia Syndrome Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Anorexia-Cachexia Syndrome Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Anorexia-Cachexia Syndrome Drug Overall Market Size
2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size: 2021 VS 2028
2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Cancer Anorexia-Cachexia Syndrome Drug Players in Global Market
3.2 Top Global Cancer Anorexia-Cachexia Syndrome Drug Companies Ranked by Revenue
3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Revenue by Companies
3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Companies
3.5 Global Cancer Anorexia-Cachexia Syndrome Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cancer Anorexia-Cachexia Syndrome Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cancer Anorexia-Cachexia Syndrome Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Anorexia-Cachexia Syndrome Drug Players in Global Market
3.8.1 List of Global Tier 1 Cancer Anorexia-Cachexia Syndrome Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Anorexia-Cachexia Syndrome Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Markets, 2021 & 2028
4.1.2 NEO-1940
4.1.3 C-1889
4.1.4 DLN-101
4.1.5 Foxo1-nRNA
4.1.6 AVGN-7
4.1.7 Others
4.2 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue & Forecasts
4.2.1 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2022
4.2.2 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2023-2028
4.2.3 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales & Forecasts
4.3.1 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2022
4.3.2 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2023-2028
4.3.3 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2017-2028
4.4 By Type - Global Cancer Anorexia-Cachexia Syndrome Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue & Forecasts
5.2.1 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2022
5.2.2 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2023-2028
5.2.3 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales & Forecasts
5.3.1 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2022
5.3.2 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2023-2028
5.3.3 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2017-2028
5.4 By Application - Global Cancer Anorexia-Cachexia Syndrome Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2021 & 2028
6.2 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue & Forecasts
6.2.1 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2022
6.2.2 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2023-2028
6.2.3 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales & Forecasts
6.3.1 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2022
6.3.2 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales, 2023-2028
6.3.3 By Region - Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2028
6.4.2 By Country - North America Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2028
6.4.3 US Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.4.4 Canada Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.4.5 Mexico Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2028
6.5.2 By Country - Europe Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2028
6.5.3 Germany Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5.4 France Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5.5 U.K. Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5.6 Italy Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5.7 Russia Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5.8 Nordic Countries Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.5.9 Benelux Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2028
6.6.2 By Region - Asia Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2028
6.6.3 China Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.6.4 Japan Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.6.5 South Korea Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.6.6 Southeast Asia Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.6.7 India Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2028
6.7.2 By Country - South America Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2028
6.7.3 Brazil Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.7.4 Argentina Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cancer Anorexia-Cachexia Syndrome Drug Sales, 2017-2028
6.8.3 Turkey Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.8.4 Israel Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
6.8.6 UAE Cancer Anorexia-Cachexia Syndrome Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Acacia Pharma Ltd
7.1.1 Acacia Pharma Ltd Corporate Summary
7.1.2 Acacia Pharma Ltd Business Overview
7.1.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.1.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.1.5 Acacia Pharma Ltd Key News
7.2 Aeterna Zentaris Inc
7.2.1 Aeterna Zentaris Inc Corporate Summary
7.2.2 Aeterna Zentaris Inc Business Overview
7.2.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.2.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.2.5 Aeterna Zentaris Inc Key News
7.3 Aphios Corp
7.3.1 Aphios Corp Corporate Summary
7.3.2 Aphios Corp Business Overview
7.3.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.3.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.3.5 Aphios Corp Key News
7.4 Incyte Corp
7.4.1 Incyte Corp Corporate Summary
7.4.2 Incyte Corp Business Overview
7.4.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.4.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.4.5 Incyte Corp Key News
7.5 Lakewood-Amedex Inc
7.5.1 Lakewood-Amedex Inc Corporate Summary
7.5.2 Lakewood-Amedex Inc Business Overview
7.5.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.5.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.5.5 Lakewood-Amedex Inc Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.6.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.6.5 Novartis AG Key News
7.7 Obexia AG
7.7.1 Obexia AG Corporate Summary
7.7.2 Obexia AG Business Overview
7.7.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.7.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.7.5 Obexia AG Key News
7.8 PsiOxus Therapeutics Ltd
7.8.1 PsiOxus Therapeutics Ltd Corporate Summary
7.8.2 PsiOxus Therapeutics Ltd Business Overview
7.8.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.8.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.8.5 PsiOxus Therapeutics Ltd Key News
7.9 RaQualia Pharma Inc
7.9.1 RaQualia Pharma Inc Corporate Summary
7.9.2 RaQualia Pharma Inc Business Overview
7.9.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.9.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.9.5 RaQualia Pharma Inc Key News
7.10 Viking Therapeutics Inc
7.10.1 Viking Therapeutics Inc Corporate Summary
7.10.2 Viking Therapeutics Inc Business Overview
7.10.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Major Product Offerings
7.10.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales and Revenue in Global (2017-2022)
7.10.5 Viking Therapeutics Inc Key News
8 Global Cancer Anorexia-Cachexia Syndrome Drug Production Capacity, Analysis
8.1 Global Cancer Anorexia-Cachexia Syndrome Drug Production Capacity, 2017-2028
8.2 Cancer Anorexia-Cachexia Syndrome Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Anorexia-Cachexia Syndrome Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Anorexia-Cachexia Syndrome Drug Supply Chain Analysis
10.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Value Chain
10.2 Cancer Anorexia-Cachexia Syndrome Drug Upstream Market
10.3 Cancer Anorexia-Cachexia Syndrome Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com